Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices

American Journal of Cardiology

Volumn 93, Issue 4, 2004, Pages 426-431

  Anzai, Hitoshi ^a   Child, John ^a   Natterson, Barbara ^a   Krivokapich, Janine ^a   Fishbein, Michael C ^a   Chan, Vicki K ^a   Tobis, Jonathan M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ADULT; ARTICLE; COMPARATIVE STUDY; DEVICE; DEVICE REMOVAL; FEMALE; HEART ATRIUM SEPTUM DEFECT; HUMAN; IMPLANTATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 1242270518     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.10.036     Document Type: Article

References (30)

1. Rao P.S. Summary and comparison of atrial septal defect closure devices. Curr Interv Cardiol Rep. 2:2000;367-376.
2. Khatchatourov G., Kalangos A., Anwar A., Urban P., De Moerloose P., Friedli B., Faidutti B. Massive thromboembolism due to transcatheter ASD closure with ASDOS device. J Invasive Cardiol. 11:1999;743-745.
3. Bohm J., Bittigau K., Kohler F., Baumann G., Konertz W. Surgical removal of atrial septal defect occlusion system-devices. Eur J Cardiothorac Surg. 12:1997;869-872.
4. Harper R.W., Mottram P.M., McGaw D.J. Closure of secundum atrial septal defects with the Amplatzer septal occluder device techniques and problems . Cathet Cardiovasc Intervent. 57:2002;508-524.
5. Latson L.A. The CardioSEAL device history, techniques, results . J Interven Cardiol. 11:1998;501-505.
6. Krumsdorf U., Keppeler P., Horvath K., Zadan E., Schrader R., Sievert H. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol. 14:2001;49-55.
7. Mas J.L., Arquizan C., Lamy C., Zuber M., Cabanes L., Derumeaux G., Coste J. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 345:2001;1740-1746.
8. Olivares-Reyes A., Chan S., Lazar E.J., Bandlamudi K., Narla V., Ong K. Atrial septal aneurysm a new classification in two hundred five adults . J Am Soc Echocardiogr. 10:1997;644-656.
9. Bartel T., Konorza T., Arjumand J., Ebradlidze T., Eggebrecht H., Caspari G., Neudorf U., Erbel R. Intracardiac echocardiography is superior to conventional monitoring for guiding device closure of interatrial communications. Circulation. 107:2003;795-797.
10. Ruiz C.E., Alboliras E.T., Pophal S.G. The puncture technique a new method for transcatheter closure of patent foramen ovale . Catheter Cardiovasc Interv. 53:2001;369-372.
11. Mazic U., Gavora P., Masura J. "Cobra-like" deformation of an Amplatzer septal occluder. Pediatr Cardiol. 22:2001;253-254.
12. Martin F., Sanchez P.L., Doherty E., Colon-Hernandez P.J., Delgado G., Inglessis I., Scott N., Hung J., King M.E., Buonanno F., et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Pediatr Cardiol. 22:2001;253-254.
13. Bruch L., Parsi A., Grad M.O., Rux S., Burmeister T., Krebs H., Kleber F.X. Transcatheter closure of interatrial communications for secondary prevention of paradoxical embolism single-center experience . Circulation. 105:2002;2845-2848.
14. Chessa M., Carminati M., Butera G., Bini R.M., Drago M., Rosti L., Giamberti A., Pome G., Bossone E., Frigiola A. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol. 39:2002;1061-1065.
15. Nkomo V.T., Theuma P., Maniu C.V., Chandrasekaran K., Miller F.A., Schaff H.V., Petty G.W., Miller T.D. Patent foramen ovale transcatheter closure device thrombosis. Mayo Clin Proc. 76:2001;1057-1061.
16. Sievert H., Babic U.U., Hausdorf G., Schneider M., Hopp H.W., Pfeiffer D., Pfisterer M., Friedli B., Urban P. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol. 82:1998;1405-1413.
17. Sievert H., Horvath K., Zadan E., Krumsdorf U., Fach A., Merle H., Scherer D., Schrader R., Spies H., Nowak B., Lissmann-Jensen H. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J Interven Cardiol. 14:2001;261-266.
18. La Rosee K., Deutsch H.J., Schnabel P., Schneider C.A., Burkhard-Meier C., Hopp H.W. Thrombus formation after transcatheter closure of atrial septal defect. Am J Cardiol. 84:1999;356-359.
19. Franke A, Kuhl HP, Muhler EG, Nussbaum J, Visser L, Lepper W, Hanrath P. Frequency of occluder-related atrial thrombi despite different prophylactic therapy after transcatheter closure of a patent foramen ovale (abstr). Eur Heart J 2000;21:25.
20. Lock J.E., Rome J.J., Davis R., Van Praagh S., Perry S.B., Van Praagh R., Keane J.F. Transcatheter closure of atrial septal defects. Experimental studies. Circulation. 79:1989;1091-1099.
21. Sharafuddin M.J., Gu X., Titus J.L., Urness M., Cervera-Ceballos J.J., Amplatz K. Transvenous closure of secundum atrial septal defects preliminary results with a new self-expanding nitinol prosthesis in a swine model . Circulation. 95:1997;2162-2168.
22. Gum P.A., Kottke-Marchant K., Welsh P.A., White J., Topol E.J. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 41:2003;961-965.
23. Freedman J.E., Adelman B. Phamacology of heparin and oral anticoagulants. Loscalzo J., Schafer A.I. Thrombosis and Hemorrhage. 1994;1155-1171 Blackwell Scientific, Boston.
24. Braun M.U., Fassbender D., Schoen S.P., Haass M., Schraeder R., Scholtz W., Strasser R.H. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 39:2002;2019-2025.
25. Windecker S., Wahl A., Chatterjee T., Garachemani A., Eberli F.R., Seiler C., Meier B. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism long-term risk of recurrent thromboembolic events . Circulation. 101:2000;893-898.
26. Meier B., Lock J.E. Contemporary management of patent foramen ovale. Circulation. 107:2003;5-9.
27. Wahl A., Meier B., Haxel B., Nedeltchev K., Arnold M., Eicher E., Sturzenegger M., Seiler C., Mattle H.P., Windecker S. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology. 57:2001;1330-1332.
28. Omeish A., Hijazi Z.M. Transcatheter closure of atrial septal defects in children & adults using the Amplatzer Septal Occluder. J Interv Cardiol. 14:2001;37-44.
29. Rao P.S., Berger F., Rey C., Haddad J., Meier B., Walsh K.P., Chandar J.S., Lloyd T.R., de Lezo J.S., Zamora R., Sideris E.B. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device comparison with first, second and third generation devices. International Buttoned Device Trial Group . J Am Coll Cardiol. 36:2000;583-592.
30. Braun M.U., Fassbender D., Schoen S.P., Haass M., Schraeder R., Scholtz W., Strasser R.H. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol. 39:2002;2019-2025.